The global molecular diagnostics devices and equipment market size is expected to grow from $24.19 billion in 2021 to $27.91 billion in 2022 at a compound annual growth rate (CAGR) of 15.3%. The global molecular diagnostics devices market is expected to grow to $46.87 billion in 2026 at a CAGR of 13.8%.
What is the Global Molecular Diagnostics Devices and Equipment Market?
The molecular diagnostics devices (or) equipment market consists of sales of molecular diagnostics devices and related services. Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in DNA or RNA at the molecular level. It helps doctors to prescribe more accurate therapeutic interventions in the early stages of a disease.
Get a Sample of the global molecular diagnostics devices and equipment market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp
What drives the Global Molecular Diagnostics Devices and Equipment Market?
The growth in the molecular diagnostic devices and equipment market is attributed to factors such as the rapid rise in various bacterial and viral epidemics. The increase in the spread of diseases increases the demand for early and improved diagnostic methods. To improve the technology to enable the early diagnosis of such diseases, the Government and different organizations extend their financial support towards the major key players of the industry. For example, according to the reports from Centres for Disease Control and Prevention (CDC) US, as of March 2019, 72 Zika virus disease cases were reported in U.S state and 148 Zika virus disease cases reported in US Territories. Thus, the rise of such chronic diseases serves as a prime driver for the players in the industry to develop more accurate and sophisticated diagnostic devices and equipment.
Get the full global molecular diagnostics devices and equipment industry report here
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report
Global Molecular Diagnostics Devices and Equipment Market Segments
The global molecular diagnostics devices and equipment market is segmented:
By Product: Instruments, Reagents, Consumables
By End-User: Diagnostic Laboratories, Hospitals, Others (Nursing Home, Blood Banks, Point of Care)
By Technology: DNA (Deoxyribonucleic Acid Sequencing), Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In Situ Hybridization, Microarrays, Mass Spectrometry, Others (Southern Blotting, Northern Blotting, Electrophoresis)
By Application: Cancer, Pharmacogenomics, Genetic Testing, Infectious Disease, Prenatal, Neurological Disease, Cardiovascular Disease
By Geography: The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Molecular Diagnostics Devices and Equipment Global Market Report 2022provides market size and growth forecasts for the global molecular diagnostics devices and equipment market, global molecular diagnostics devices and equipment market share, molecular diagnostics devices and equipment market segments and geographies, molecular diagnostics devices and equipment market competitive landscape including leading competitors’ revenues, profiles and market shares. The molecular diagnostics devices and equipment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Molecular Diagnostics Devices and Equipment Industry Playersinclude Roche Ltd, Hologic, QIAGEN, Abbott, Danaher Corporation, Bio-Rad Laboratories, Siemens Healthcare, Becton Dickinson and Company, Cepheid Inc, and bioMerieux S.A. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
